Prospective Clinical Study of ZPR Regimen in Relapsed/Refractory Diffuse Large B-cell Lymphoma

Condition:   Diffuse Large B Cell Lymphoma Intervention:   Drug: Zanubrutinib, Polatuzumab vedotin and Rituximab Sponsor:   Peng Liu Recruiting

Source: ClinicalTrials.gov - July 11, 2023 Category: Research Source Type: clinical trials